FDA recall D-0426-2026

Fresenius Kabi USA, LLC · Class II · drug

Product

0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 mL in a 100 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 600047, Unit of Use NDC: 65219-468-05, Unit of Sale NDC Number: 65219-468-50.

Reason for recall

Lack of Assurance of Sterility

Distribution

US Nationwide , Alaska, and Puerto Rico.

Key facts

Status
Ongoing
Initiation date
2026-03-11
Report date
2026-04-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
Lake Zurich, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0426-2026